SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fermenta Biotech - Quaterly Results

12 Aug 2024 Evaluate
The sales for the June 2024 quarter moved down to Rs. 726.98 millions as compared to Rs. 767.75 millions during the year-ago period.The Net Loss for the quarter ended June 2024 is Rs. -48.51 millions as compared to Net Profit of Rs. 47.90 millions of corresponding quarter ended June 2023A decline of 44.37 millions was observed in the OP in the quarter ended June 2024 from 152.40 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 726.98 767.75 -5.31 726.98 767.75 -5.31 3070.90 3289.14 -6.64
Other Income 26.28 20.54 27.95 26.28 20.54 27.95 81.54 84.62 -3.64
PBIDT 44.37 152.40 -70.89 44.37 152.40 -70.89 451.40 468.98 -3.75
Interest 34.23 47.57 -28.04 34.23 47.57 -28.04 170.52 208.02 -18.03
PBDT 10.14 104.83 -90.33 10.14 104.83 -90.33 190.88 -334.93 -156.99
Depreciation 58.65 56.93 3.02 58.65 56.93 3.02 236.96 244.85 -3.22
PBT -48.51 47.90 -201.27 -48.51 47.90 -201.27 -46.08 -579.78 -92.05
TAX 0.00 0.00 0.00 0.00 0.00 0.00 141.36 -9.74 -1551.33
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 124.56 -11.56 -1177.51
PAT -48.51 47.90 -201.27 -48.51 47.90 -201.27 -187.44 -570.04 -67.12
Equity 144.47 144.29 0.12 144.47 144.29 0.12 144.37 144.29 0.06
PBIDTM(%) 6.10 19.85 -69.25 6.10 19.85 -69.25 14.70 14.26 3.09

Fermenta Biotech Share Price

321.00 -0.85 (-0.26%)
17-Apr-2026 11:02 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1682.60
Dr. Reddys Lab 1223.00
Cipla 1237.70
Zydus Lifesciences 946.35
Lupin 2317.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×